Cardiovascular Disease in Delray Beach, FL
25 verified cardiovascular disease doctors in Delray Beach.
Cardiologists diagnose and treat conditions of the heart and blood vessels, including heart disease, arrhythmias, and heart failure.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Charles Harring, MD
Cardiovascular Disease
CMS Open Payments· $3,113 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$3,113
Total received
122
Transactions
29
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 85th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Charles Harring do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Bruce Martin, MD
Cardiovascular Disease
CMS Open Payments· $1,458 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,458
Total received
66
Transactions
16
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 78th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Bruce Martin do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Richard Kim, MD
Cardiovascular Disease
CMS Open Payments· $17,331 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$17,331
Total received
92
Transactions
23
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is higher than 92% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Richard Kim do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Alan Zelcer, MD
Cardiovascular Disease
CMS Open Payments· $1,060 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,060
Total received
48
Transactions
14
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 74th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Alan Zelcer do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Carlos Cowley, MD
Cardiovascular Disease
CMS Open Payments· $237.45 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$237.45
Total received
6
Transactions
5
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 54th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Carlos Cowley do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Angelo Pace, MD
Cardiovascular Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Michael Anesta, MD
Cardiovascular Disease
CMS Open Payments· $470.51 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$470.51
Total received
12
Transactions
7
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 63th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Michael Anesta do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Mitchell Silver, MD
Cardiovascular Disease
CMS Open Payments· $118.92 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$118.92
Total received
6
Transactions
3
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is on the lower end — around the 47th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Mitchell Silver do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Stephen Saltz, MD
Cardiovascular Disease
CMS Open Payments· $374.58 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$374.58
Total received
12
Transactions
11
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 60th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Stephen Saltz do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Ronald Blankstein, MD
Cardiovascular Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Arthur Weiner, MD
Cardiovascular Disease
CMS Open Payments· $290.79 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$290.79
Total received
2
Transactions
2
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 57th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Arthur Weiner do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Eric Lieberman, MD
Cardiovascular Disease
CMS Open Payments· $290.77 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$290.77
Total received
2
Transactions
2
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 57th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Eric Lieberman do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Mark Fisher, MD
Cardiovascular Disease
CMS Open Payments· $144.48 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$144.48
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is on the lower end — around the 49th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Mark Fisher do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Steven Cohen, MD
Cardiovascular Disease
CMS Open Payments· $41,708 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$41,708
Total received
127
Transactions
27
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is higher than 95% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Steven Cohen do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Martin Bloom, MD
Cardiovascular Disease
CMS Open Payments· $20.87 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$20.87
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is on the lower end — around the 37th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Martin Bloom do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Alexander Chaplik, MD
Cardiovascular Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Alan Lieberman, MD
Cardiovascular Disease
CMS Open Payments· $464.75 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$464.75
Total received
14
Transactions
9
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 63th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Alan Lieberman do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Robert Carida, MD
Cardiovascular Disease
CMS Open Payments· $2,260 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$2,260
Total received
76
Transactions
21
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 83th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Robert Carida do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Steven Hornreich, MD
Cardiovascular Disease
CMS Open Payments· $669.67 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$669.67
Total received
7
Transactions
4
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 68th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Steven Hornreich do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Gustavo Cardenas, MD
Cardiovascular Disease
CMS Open Payments· $3,270 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$3,270
Total received
113
Transactions
31
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 86th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Gustavo Cardenas do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Neil Shachter, MD
Cardiovascular Disease
CMS Open Payments· $6,998 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$6,998
Total received
6
Transactions
1
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 89th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Neil Shachter do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Michael Metzger, MD
Cardiovascular Disease
CMS Open Payments· $12,865 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$12,865
Total received
126
Transactions
31
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is higher than 91% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Michael Metzger do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Phillip Habib, MD
Cardiovascular Disease
CMS Open Payments· $56,852 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$56,852
Total received
50
Transactions
9
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is higher than 96% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Phillip Habib do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Jonathan Kahan, MD
Cardiovascular Disease
CMS Open Payments· $3,261 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$3,261
Total received
5
Transactions
3
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 86th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Jonathan Kahan do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Tiffany Larue, MD
Cardiovascular Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.